Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients

Journal of Proteome Research

Volumn 9, Issue 8, 2010, Pages 4170-4175

  Guo, Weixing ^a   Xue, Jie ^a   Shi, Jie ^a   Li, Nan ^a   Shao, Yu ^b   Yu, Xiya ^b   Shen, Feng ^a   Wu, Mengchao ^a   Liu, Shanrong ^b   Cheng, Shuqun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

c kit; hepatocellular carcinoma; portal vein tumor thrombosis; proteomics

Indexed keywords

ALPHA 1 TYPE 3 COLLAGEN; CHAPERONIN 10 RELATED PROTEIN; COLLAGEN; CYCLINE; CYCLOPHILIN B; FRUCTOSE BISPHOSPHATE ALDOLASE; GALECTIN 1; NUCLEOSIDE DIPHOSPHATE KINASE; PEROXIREDOXIN 1; PROTEIN ACTB; PROTEIN HMGBI; PROTEIN HP2 ALPHA; PROTEIN P53 INDUCIBLE PROTEIN 3; STATHMIN 1; STEM CELL FACTOR RECEPTOR; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER TISSUE; CELL LINE; CELL STRAIN CSQT 2; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PORTAL VEIN; PORTAL VEIN THROMBOSIS; PORTAL VEIN TUMOR THROMBOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TUMOR THROMBUS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; VALIDATION PROCESS; VASCULAR TUMOR;

ADULT; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PORTAL VEIN; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOSIS;

EID: 77955463327     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100412w     Document Type: Article

References (36)

1. Pisani, P.; Parkin, D. M.; Bray, F.; Ferlay, J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990 Int. J. Cancer 1999, 83 (6) 870-873; Int. J. Cancer 1999, 83, 18-29
2. Ji, J.; Shi, J.; Budhu, A.; Yu, Z.; Forgues, M.; Roessler, S.; Ambs, S.; Chen, Y.; Meltzer, P. S.; Croce, C. M.; Qin, L. X.; Man, K.; Lo, C. M.; Lee, J.; Ng, I. O.; Fan, J.; Tang, Z. Y.; Sun, H. C.; Wang, X. W. MicroRNA expression, survival, and response to interferon in liver cancer N. Engl. J. Med. 2009, 361 (15) 1437-47
3. Zhang, X.; Liu, S.; Hu, T.; Liu, S.; He, Y.; Sun, S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression Hepatology 2009, 50 (2) 490-9
4. Zhu, X. D.; Zhang, J. B.; Zhuang, P. Y.; Zhu, H. G.; Zhang, W.; Xiong, Y. Q.; Wu, W. Z.; Wang, L.; Tang, Z. Y.; Sun, H. C. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma J. Clin. Oncol. 2008, 26 (16) 2707-16
5. Yamanaka, N.; Okamoto, E.; Fujihara, S.; Kato, T.; Fujimoto, J.; Oriyama, T.; Mitsunobu, M.; Toyosaka, A.; Uematsu, K.; Yamamoto, K. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection Cancer 1992, 70 (9) 2263-7
6. Llovet, J. M.; Bruix, J. Novel advancements in the management of hepatocellular carcinoma in 2008 J. Hepatol. 2008, 48, S20-37 suppl 1
7. Lencioni, R.; Caramella, D.; Sanguinetti, F.; Battolla, L.; Falaschi, F.; Bartolozzi, C. Portal vein thrombosis after percutaneous ethanol injection for hepatocellular carcinoma: value of color Doppler sonography in distinguishing chemical and tumor thrombi AJR Am. J. Roentgenol. 1995, 164 (5) 1125-30
8. Li, N.; Lai, E. C.; Shi, J.; Guo, W. X.; Xue, J.; Huang, B.; Lau, W. Y.; Wu, C.; Cheng, S. Q. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection Ann. Surg. Oncol. 2010, 17 (1) 179-85
9. Qiu, J. G.; Fan, J.; Liu, Y. K.; Zhou, J.; Dai, Z.; Huang, C.; Tang, Z. Y. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma J. Cancer Res. Clin. Oncol. 2008, 134 (3) 299-305
10. Shuqun, C.; Mengchao, W.; Han, C.; Feng, S.; Jiahe, Y.; Guanghui, D.; Wenming, C.; Peijun, W.; Yuxiang, Z. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein Hepatogastroenterology 2007, 54 (74) 499-502
11. Zeng, Z. C.; Fan, J.; Tang, Z. Y.; Zhou, J.; Wang, J. H.; Wang, B. L.; Guo, W. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy Cancer Sci. 2008, 99 (12) 2510-7
12. Ye, Q. H.; Qin, L. X.; Forgues, M.; He, P.; Kim, J. W.; Peng, A. C.; Simon, R.; Li, Y.; Robles, A. I.; Chen, Y.; Ma, Z. C.; Wu, Z. Q.; Ye, S. L.; Liu, Y. K.; Tang, Z. Y.; Wang, X. W. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat. Med. 2003, 9 (4) 416-23
13. Liu, S.; Foster, B. A.; Chen, T.; Zheng, G.; Chen, A. Modifying dendritic cells via protein transfer for antitumor therapeutics Clin. Cancer Res. 2007, 13 (1) 283-91
14. Chen, R.; Zhu, D.; Ye, X.; Shen, D.; Lu, R. Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro Sci. Sin. 1980, 23 (2) 236-47
15. Li, Y.; Tang, Z. Y.; Ye, S. L.; Liu, Y. K.; Chen, J.; Xue, Q.; Chen, J.; Gao, D. M.; Bao, W. H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97 World J. Gastroenterol. 2001, 7 (5) 630-6
16. Pan, X. B.; Wei, L.; Chen, H. S.; Liu, F.; Gao, Y. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns Arch. Virol. 2007, 152 (6) 1159-73
17. Tian, J.; Tang, Z. Y.; Ye, S. L.; Liu, Y. K.; Lin, Z. Y.; Chen, J.; Xue, Q. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis Br. J. Cancer 1999, 81 (5) 814-21
18. Wang, T.; Hu, H. S.; Feng, Y. X.; Shi, J.; Li, N.; Guo, W. X.; Xue, J.; Xie, D.; Liu, S. R.; Wu, M. C.; Cheng, S. Q. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma Br. J. Cancer 2009, 102 (11) 1618-26
19. Cui, J. F.; Liu, Y. K.; Pan, B. S.; Song, H. Y.; Zhang, Y.; Sun, R. X.; Chen, J.; Feng, J. T.; Tang, Z. Y.; Yu, Y. L.; Shen, H. L.; Yang, P. Y. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins J. Cancer Res. Clin. Oncol. 2004, 130 (10) 615-22
20. Yu, L. R.; Zeng, R.; Shao, X. X.; Wang, N.; Xu, Y. H.; Xia, Q. C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry Electrophoresis 2000, 21 (14) 3058-68
21. Hu, T.; Liu, S.; Breiter, D. R.; Wang, F.; Tang, Y.; Sun, S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis Cancer Res. 2008, 68 (16) 6533-40
22. Adams, L.; Scott, G. K.; Weinberg, C. S. Biphasic modulation of cell growth by recombinant human galectin-1 Biochim. Biophys. Acta 1996, 1312 (2) 137-44
23. Banerjee, S.; Kundu, T. K. The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription Nucleic Acids Res. 2003, 31 (12) 3236-47
24. Prochownik, E. V. Functional and physical communication between oncoproteins and tumor suppressors Cell. Mol. Life Sci. 2005, 62 (21) 2438-59
25. Yuan, R. H.; Jeng, Y. M.; Chen, H. L.; Lai, P. L.; Pan, H. W.; Hsieh, F. J.; Lin, C. Y.; Lee, P. H.; Hsu, H. C. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma J. Pathol. 2006, 209 (4) 549-58
26. Fujio, K.; Evarts, R. P.; Hu, Z.; Marsden, E. R.; Thorgeirsson, S. S. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat Lab. Invest. 1994, 70 (4) 511-6
27. Omori, M.; Evarts, R. P.; Omori, N.; Hu, Z.; Marsden, E. R.; Thorgeirsson, S. S. Expression of alpha-fetoprotein and stem cell factor/c-kit system in bile duct ligated young rats Hepatology 1997, 25 (5) 1115-22
28. Shiojiri, N.; Lemire, J. M.; Fausto, N. Cell lineages and oval cell progenitors in rat liver development Cancer Res. 1991, 51 (10) 2611-20
29. Thorgeirsson, S. S. Hepatic stem cells in liver regeneration FASEB J. 1996, 10 (11) 1249-56
30. Lahm, H.; Andre, S.; Hoeflich, A.; Kaltner, H.; Siebert, H. C.; Sordat, B.; von der Lieth, C. W.; Wolf, E.; Gabius, H. J. Tumor galectinology: insights into the complex network of a family of endogenous lectins Glycoconj. J. 2004, 20 (4) 227-38
31. Salatino, M.; Croci, D. O.; Bianco, G. A.; Ilarregui, J. M.; Toscano, M. A.; Rabinovich, G. A. Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer Expert Opin. Biol. Ther. 2008, 8 (1) 45-57
32. Bram, R. J.; Crabtree, G. R. Calcium signalling in T cells stimulated by a cyclophilin B-binding protein Nature 1994, 371 (6495) 355-8
33. Bukrinsky, M. I. Cyclophilins: unexpected messengers in intercellular communications Trends Immunol. 2002, 23 (7) 323-5
34. Clevenger, C. V. Role of prolactin/prolactin receptor signaling in human breast cancer Breast Dis. 2003, 18, 75-86
35. Fujio, K.; Hu, Z.; Evarts, R. P.; Marsden, E. R.; Niu, C. H.; Thorgeirsson, S. S. Coexpression of stem cell factor and c-kit in embryonic and adult liver Exp. Cell Res. 1996, 224 (2) 243-50
36. Ramadori, G.; Fuzesi, L.; Grabbe, E.; Pieler, T.; Armbrust, T. Successful treatment of hepatocellular carcinoma with the tyrosine kinase inhibitor imatinib in a patient with liver cirrhosis Anticancer Drugs 2004, 15 (4) 405-9